Bédard P J, Boucher R
Département d'anatomie et Laboratoire de Neurobiologie, Faculté de Médecine, Université Laval, Québec, Canada.
Neurosci Lett. 1989 Sep 25;104(1-2):223-8. doi: 10.1016/0304-3940(89)90358-3.
The effect of a selective agonist of the dopamine D1 receptor (SKF 38393) and of the D2 receptor (LY-171555) was tested acutely in normal and in monkeys with a parkinsonian syndrome induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). The D2 agonist induced a strong locomotor response and lingual dyskinesia in both normal and parkinsonian monkeys. The D1 agonist however had no locomotor effect by itself but induced tongue protrusions in normal monkeys only. It appeared to potentiate the dyskinetic effect of LY 171555 in MPTP monkeys but it antagonized the locomotor action of the D2 agonist in both normal and MPTP monkeys. The selective D1 and D2 antagonists SCH 23390 and sulpiride were also tested. Both compounds were able to suppress the dyskinetic action of the combined agonists in normal animals but only the D2 antagonist was effective in the same conditions in MPTP monkeys. These findings emphasize the importance of the D2 receptor in mediating the locomotor response as well as dyskinesia in monkeys.
在正常猴子以及由1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)诱导出帕金森综合征的猴子中,对多巴胺D1受体选择性激动剂(SKF 38393)和D2受体选择性激动剂(LY-171555)的作用进行了急性测试。D2激动剂在正常猴子和帕金森病猴子中均诱发了强烈的运动反应和舌运动障碍。然而,D1激动剂本身没有运动效应,但仅在正常猴子中诱发了伸舌动作。它似乎增强了LY 171555对MPTP猴子的运动障碍作用,但在正常猴子和MPTP猴子中均拮抗了D2激动剂的运动作用。还测试了选择性D1和D2拮抗剂SCH 23390和舒必利。两种化合物都能够抑制联合激动剂在正常动物中的运动障碍作用,但只有D2拮抗剂在相同条件下对MPTP猴子有效。这些发现强调了D2受体在介导猴子运动反应以及运动障碍中的重要性。